α2-adrenoceptors and I1-imidazoline binding sites: Relationship with catecholamines in women of reproductive age

Journal of Psychiatric Research

Volumn 32, Issue 2, 1998, Pages 55-64

  Piletz, J E ^a,b   Andrew, M ^a   Zhu, H ^a   Feng, Y Z ^a   Rains, J ^a   Halaris, A ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Clonidine; Depression; Epinep hrine; Imidazoline receptors; Norepinephrine; Platelets; 2 adrenoceptors

Indexed keywords

ADRENALIN; ALPHA 2 ADRENERGIC RECEPTOR; IMIDAZOLINE I1 RECEPTOR; NORADRENALIN;

ADRENALIN BLOOD LEVEL; ADULT; ARTICLE; BINDING SITE; FEMALE; HUMAN; HUMAN EXPERIMENT; MENSTRUAL CYCLE; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL;

EID: 0032029559     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3956(98)00048-X     Document Type: Article

References (41)

1. Blum I, Nessiel L, David A, Graff E, Harsat A, Weissglas L, Gabbay U, Sulkes J, Yerushalmy Y, Vered Y. Plasma neurotransmitter profile during different phases of the ovulatory cycle. Journal of Clinical Endocrinology and Metabolism 1992;75:924-9.
2. Egan B, Neubig R, Julius S. Pharmacologic reduction of sympathetic drive increases platelet α-2 receptor number. Clinical Pharmacological Therapeutics 1985;38:519-24.
3. 1-imidazoline receptors: definition, characterization, distribution, and transmembrane signaling. In Reis DJ, Bousquet P, Parini A, editors. The imidazoline receptor: pharmacology, functions, ligands, and relevance to biology and medicine, Vol. 763, Annals of New York Academy of Sciences, New York. 1995a. pp. 22-42.
4. Ernsberger P, Piletz JE, Graff LM, Graves ME. Optimization of radioligand binding assays for I-1 imidazoline sites. In Reis DJ, Bousquet P, Parini A, editors. The imidazoline receptor: pharmacology, functions, ligands, and relevance to biology and medicine, Vol. 763, Annals of New York Academy of Sciences, New York. 1995b. pp. 163-8.
5. 1-imidazoline binding sites. Neurochemistry International 1996;30:17-24.
6. Evinger MJ, Ernsberger P, Regunathan S, Reis DJ. Regulation of phenylethanolamine N-methyltransferase gene expression by imidazoline receptors in adrenal chromaffin cells. Journal of Neurochemistry 1995;65:988-97.
7. 2-adrenoreceptor interaction. The Journal of Biological Chemistry 1986;261:5981-6.
8. Freedman M, Altszuler N, Karpatkin S. Presence of a non-splenic platelet pool. Blood 1997;50:419-22.
9. 2-adrenergic receptors in human platelets. Psychosomatic Medicine 1990;52:624-30.
10. Fuder H, Schwarz P. Desensitization of inhibitory prejunctional α-2 adrenoceptors and putative imidazoline receptors on rabbit heart sympathetic nerves. Naunyn-Schmiedeberg's Archives of Pharmacology 1993;348:127-33.
11. Garcia-Sevilla JA, Escriba PV, Sastre M, Walzer C, Busquets X, Jaquet G, Reis DJ, Guimon J. Immunodetection and quantitation of imidazoline receptor proteins in platelets of patients with major depression and in brains of suicide victims. Archives of General Psychiatry, 1996;53:803-10.
12. Goldstein DS, Levinson P, Keiser HR. Plasma and urinary catecholamines during the human ovulatory cycle. American Journal of Obstetrics and Gynecology 1983;146:825-29.
13. Gothert M, Molderings GJ. Involvement of presynaptic imidazoline receptors in the α-2-adrenoceptor independent inhibition of noradrenaline release by imidazoline derivatives. Naunyn-Schmiedeberg's Archives of Pharmacology 1991;343:271-82.
14. Grossman F, Manji HK, Potter WZ. Platelet α-2 adrenoceptors in depression: a critical examination. Journal of Psychopharmacology 1993;7:4-18.
15. Halbreich U, Piletz JE, Carson S, Halaris A, Rojansky N. Increased imidazoline and α-2 adrenergic binding in platelets of women with dysphoric premenstrual syndromes. Biological Psychiatry 1993;34:676-86.
16. Hamilton CA, Deighton NM, Reid JL. Rapid and reversible desensitization of vascular and platelet α-2 adrenoceptors. Naunyn-Schmiedeberg's Archives of Pharmacology 1987;335:534-40.
17. Jones SB, Bylund DB, Rieser CA, Shekim W, Byer JA, Carr GW. α-2 adrenergic receptor binding in human platelets: alterations during the menstrual cycle. Clinical Pharmacological Therapeutics 1983;34:90-6.
18. Kiecolt-Glaser JK, Newton T, Cacioppo JT, MacCallum RC, Glaser R, Malarkey WB. Marital conflict and endocrine function: are men really more physiologically affected than women? J. Consulting and Clin Psychol 1996;64:324-32.
19. Lechin F, van der Djis B, Orozco B, Lechin ME, Baez S, Lechin AE, Rada I, Acosta E, Arocha L, Jimenez V. Plasma neurotransmitters, blood pressure, and heart rate during supine-resting, orthostasis, and moderate exercise conditions in major depressed patients. Biol Psychiatry 1995;38:166-73.
20. Li G, Regunathan S, Barrow CJ, Eshraghi J, Cooper R, Reis DJ. Agmatine: an endogenous clonidine-displacing substance in the brain. Science 1994;263:966-9.
21. Manji HK, Rudorfer MV, Potter WZ. Affective disorders and adrenergic function. In Cameron OG, editor. Adrenergic Dysfunction and Psychobiology, Vol., American Psychiatric Press Inc., Washington, D.C. 1994. pp. 365-401.
22. McPherson CA. Analysis of radioligand binding experiments. A collection of computer programs for the IBM PC. Journal of Pharmacological Methods 1985;14:213-28.
23. Noshiro T, Miura Y, Kimura S, Meguro Y, Sugawara T, Ohashi H, Takahashi M, Sano N, Watanabe H, Ohzeki T, Shimizu K, Yoshinaga K. Functional relationship between platelet α-2-adrenoceptors and sympathetic nerve activity in clinical hypertensive states. Journal of Hypertension 1990;8:1097-104.
24. Neubig RR, Szamraj O. Large-scale purification of α-2-adrenergic receptor-enriched membranes from human platelets. Persistent association of guanine nucleotides with nonpurified membranes. Biochimica et Biophysica Acta 1986;854:67-6.
25. Nguyen TT, DeLean, A. Nonadrenergic modulation by clonidine of the cosecretion of catecholamines and enkephalins in adrenal chromaffin cells. Canadian Journal of Physiology and Pharmacology 1987;65: 823-7.
26. Ohara-Imaizumi M, Kumakura K. Effects of imidazole compounds on catecholamine release in adrenal chromaffin cells. Cellular and Molecular Neurobiology 1992;12:273-83.
27. Piletz JE, Chikkala D, Khaitan L, Jackson K, Qu YS. Delayed desensitization of α-2 adrenoceptor-mediated platelet aggregation in depressed patients. Neuropsychopharmacology 1993;9:55-66.
28. Piletz JE, Ernsberger PR, Halaris A. Psychopharmacology of imidazoline and α-2 adrenergic receptors: implications for depression. CRC Critical Reviews in Neurobiology 1995;9:29-66.
29. 3H]-para-aminoclonidine binding to different platelet preparations. Journal of Neural Transmission 1990;82:11-29.
30. 1-imidazoline receptors in mood disorders. In Reis DJ, Bousquet P, Parini A, editors. The imidazoline receptor: pharmacology, functions, ligands, and relevance to biology and medicine, Vol.763, Annals of New York Academy of Sciences, New York. 1995. pp. 510-9.
31. 3H]-para-aminoclonidine binding in platelets of depressed patients. Archives of General Psychiatry 1991;48:813-20.
32. 1-imidazoline binding sites are decreased by two dissimilar antidepressant agents in depressed patients. Journal of Psychiatric Research 1996a;30:169-84.
33. 1-imidazoline binding sites are elevated in depression but not generalized anxiety disorder. Journal of Psychiatric Research 1996b;30: 147-68.
34. Piletz JE, Sletten K. Nonadrenergic imidazoline binding sites on human platelets. The Journal of Pharmacology and Experimental Therapeutics 1993;267:1493-502.
35. 2-adrenoceptors do not regulate catecholamine secretion by bovine adrenal medullary cells: a study with clonidine. Molecular Pharmacology 1986;29:134-41.
36. Reiger DA, Boyd JH, Burke JD, Rae DS, Kramer M, Robins L, George LK, Karno M, Lock BT. One month prevalence of mental disorder in the United States. Archives of General Psychiatry 1988;45:977-86.
37. Rosen SG, Berk MA, Popp DA, Serusclat P, Smith EB, Shah SD, Ginsberg AM, Clutter WE, Cryer PE. β-2 and α-2 adrenergic receptors and receptor coupling to adenylate cyclase in human mononuclear leukocytes and platelets in relation to physiological variations of sex steroids. Journal of Clinical Endocrinology and Metabolism 1984;58:1068-76.
38. Stowell LI, McIntosh CJ, Cooke R, Ellis PM. Adrenoceptor and imipramine receptor binding during the menstrual cycle. Acta Psychiatrica Scandinavica 1988;78:366-8.
39. Sundaresan PR, Madan MK, Kelvie SL, Weintraub M. Platelet α-2 adrenoceptors and the menstrual cycle. Clinical Pharmacological Therapeutics 1985;37:337-42.
40. Theodorou AE, Mistry H, Davies SL, Yamaguchi Y. Horton RW. Platelet a-2 adrenoceptor binding and function during the menstrual cycle. Journal of Psychiatric Research 1987;21:163-9.
41. Tibirica E, Feldman J, Mermet C, Gonon F, Bousquet P. An imidazoline-specific mechanism for the hypotensive effect of clonidine: a study with yohimbine and idazoxan. The Journal of Pharmacology and Experimental Therapeutics 1991;256:606-13.